Tracer library / [111In]In-minigastrin

[111In]In-minigastrin

Also written as [111In]In-minigastrin

Radionuclide: In-111
Modality: —
Production route: —
Stage: —
Syntheses indexed: 2

What it is

Compound class: Minigastrin peptide analogue (CCK2/gastrin receptor-binding peptide)
Target / mechanism: CCK2/gastrin receptor PMID 21993546
Clinical application: Medullary thyroid carcinoma (preclinical animal model) PMID 21993546
Theranostic pair: —

Published syntheses

Module	Cassette	Purification	Yield %	RCP %	Precursor / supplier	Source
—	—	—	—	>95%	[DOTA-Glu1]-minigastrin Peptide Specialty Laboratories	21170526 2011 Eur J Nucl Med Mol Imaging
Manual synthesis	—	—	—	>95%	[DOTA-Glu1]-minigastrin Peptide Specialty Laboratories	19722105 2010 Eur J Nucl Med Mol Imaging Minigastrin was labelled with 111InCl3 in a 0.25 M ammonium acetate buffer, pH 5.5. 111InCl3 (22.2 MBq) was added to 1 µg of minigastrin and the mixture was incubated at 95°C for 25 min.

Precursor

Common precursor: —
Suppliers seen in the literature: —
Cited suppliers in indexed syntheses: Peptide Specialty Laboratories
Typical final purification: —

Need this precursor?We can point you to suppliers for [111In]In-minigastrin, or handle the enquiry for you.

Get in touch

Notes

Added at stage 39 (2026-09-27) from a reverse search of the PubMed corpus's own unattached articles (articles that named a real compound not yet in this reference): 2 article(s) found under this name, not yet individually researched. Target/mechanism, clinical application, indications, approval, modality, stage and production route are intentionally left empty. PMIDs: 19722105, 21993546.